US 20060280786 A1

Pharmaceutical Formulations for Minimizing Drug-Drug Interactions
(describing formulations using two or more drugs)

Baxter Healthcare
Deerfield, IL

US 20060024240 A1

Delivery of AS-Oligonucleotide Microspheres to Induce Dendritic Cell Tolerance For the Treatment of Autoimmune Type I Diabetes
(describing the formulation of antisense oligonucleotides for a specific applications)

Baxter Healthcare
Deerfield, IL

US 20060293243 A1

Stable, Buffered, Pharmaceutical Compositions Including Motilin-Like Peptides
(describing peptide formulations for therapy)

Baxter Healthcare
Deerfield, IL

US 20060018971 A1

Nucleic Acid Microspheres, Production and Delivery Thereof
(describing the formulation of antisense oligonucleotides)

Baxter Healthcare
Deerfield, IL

US 20050202000 A1

Novel Recombinant Staphylokinase Derivative and its Preparation Thereof
(describing the production of novel recombinant proteins)

Fudan University, Shanghai

US 20050112648 A1

Genetic Markers for Pig Backfat Thickness
(describing a diagnostic genetic test)

Animal Technology Institute of Taiwan

US 20070253983 A1

Augmentation of Titer for Vaccination in Animals
(describing a composition that improves the immune response)

OmniGen Research, LLC
Independence, OR

WO/2007/084969

System For Making Products With Improved Particle Morphology And Particle Distribution And Products
(describing methods of production in the Biofuel Industry)

Precision Fuel Technology
Independence, MN

US 7,052,603

Single-use Manifold for Automated, Aseptic Transfer of Solutions in Bioprocessing Applications
(describing a manifold system for use in biotechnological applications)

Scilog
Madison, WI